90349-67-0Relevant academic research and scientific papers
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 0418-0420, (2020/05/14)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
TYK2 PSEUDOKINASE LIGANDS
-
Paragraph 00131, (2020/08/22)
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 0407; 0408; 0409; 0410; 0443; 0444; 0445, (2019/02/13)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
Pyrazolo[1,5-a]pyrimidine derivatives
-
Page/Page column 67, (2010/11/08)
The Pyrazolo[1,5-a]pyrimidine derivatives represented by formula I and their pharmaceutically acceptable salts exhibit excellent MAPKAP-K2 inhibiting activity. Drugs comprising the compounds as effective ingredients are therefore expected to be useful as
